AI's pie is getting bigger and bigger, so why is Tesla still struggling to win over Wall Street?
Tesla's third-quarter revenue was $28 billion, and its gross margin of 19.6% beat expectations, but EBIT was only $718 million. Goldman Sachs, Morgan Stanley, and JPMorgan all maintained Neutral ratings, with target prices of $360 and $400 and a neutral stance, respectively. The take rate of FSD on new vehicles in North America rose from 55% to more than 75%, Robotaxi cumulative mileage increased from 1 million miles to 3.1 million miles, and the energy storage gross margin reached 33.1%. The Optimus mass-production target is 10,000 to 20,000 units within 12 months, and commercial sales to external customers have been postponed to the end of 2027.
Body · AI translation
Tesla's third-quarter earnings show that the company has made phased progress in its autonomous driving, energy storage and robotics businesses, and its gross margin also beat expectations, but persistently high operating expenses, lower-than-expected profitability and a still-distant timeline for commercial monetization have led mainstream Wall Street investment banks to maintain a wait-and-see stance. This company, with a market value of $1.6 trillion, is facing an increasingly thorny dilemma: the bigger the story gets, the harder it is for the valuation to hold up.
Tesla's third-quarter revenue was $28 billion, with EBIT of only $718 million, far below the expectations of Goldman Sachs and Morgan Stanley, with higher-than-expected operating expenses the main drag. Although non-GAAP diluted earnings per share of $0.48 slightly beat expectations, Goldman Sachs has already cut its 2026-2027 EPS forecasts, citing persistently rising operating costs. As for the stock price, Goldman Sachs maintains a Neutral rating and a $360 target price, implying about 7% downside from the current share price; Morgan Stanley likewise maintains a Neutral rating with a $400 target price; JPMorgan has a Neutral rating on Tesla shares.
The three major investment banks have rarely formed a consensus: the progress is real, but the valuation has fully priced it in, and is even overly full.
Nevertheless, the bright spots in the earnings report should not be overlooked. The FSD take rate on new vehicles in North America rose from 55% in the second quarter to more than 75%, and cumulative Robotaxi miles grew from 1 million to 3.1 million in just a few weeks; the energy storage business's gross margin rose to 33.1%, and the Megapack backlog hit a record high. These data provide real support for Tesla's long-term narrative, and are also the underlying logic behind why most analysts have not completely given up on this stock.
Gross Margin Surprise, Profit Narrative Stalled
Tesla's overall gross margin in the third quarter was 19.6%, beating expectations across the board—Goldman Sachs forecast 18.5%, the company's compiled market consensus was 17.9%, and the FactSet figure was 17.5%.
Among them, the automotive business gross margin (including stock-based compensation, excluding carbon credits) reached 18.1%, beating Goldman Sachs' forecast of 16.3%; the energy storage business gross margin was 33.1%, also far exceeding Morgan Stanley's forecast of 26.5%; and the services business gross margin was 15.9%, a record high.
However, the gross margin beat was offset by out-of-control expenses. Third-quarter EBIT was only $718 million, clearly below Goldman Sachs' forecast of $1.043 billion and Morgan Stanley's forecast of $526 million; R&D expenses were $2.761 billion, about 11% higher than Morgan Stanley's forecast. Management explicitly stated that to support the expansion of AI and energy businesses—including Optimus, Robotaxi and Megapack—operating expenses and capital expenditures will continue to grow quarter over quarter.
Goldman Sachs promptly cut its 2026-2027 EPS forecasts, from $0.82 and $1.75 to $0.67 and $1.60, respectively, while slightly raising its 2028 forecast to $2.50.
JPMorgan also takes a cautious view. Based on the current share price, the 2028 expected P/E ratio is still as high as 154 times, and the free cash flow yield is negative in both 2026 and 2027, meaning investors need to pay an extremely high premium for the distant future.
Robotaxi and FSD: Milestones Accelerating, but Commercialization Still Early
Robotaxi was the business development that drew the most market attention this quarter. As of October 18, Tesla's fully driverless Robotaxi cumulative miles reached 3.1 million, more than tripling from about 1 million miles on September 3, with a weekly growth rate of about 20%, exceeding the upper end of Goldman Sachs' previous forecast range of 2 million to 3 million miles.
According to a Goldman Sachs research report, since Tesla began fully unsupervised operations on January 22, 2026, an accident has occurred on average about every 100,000 miles (regardless of fault or severity); by comparison, Waymo averaged one every 180,000 miles between July 2025 and August 2026, and recent data has reached one every 360,000 miles. A gap remains, but Tesla's pace of improvement cannot be ignored.
On geographic expansion, management said Cybercab has begun operating in Austin and is expected to launch in Dallas next month; San Antonio and Jacksonville have been added to the list of subsequent expansion cities, and previously announced Phoenix and Las Vegas are also progressing.
FSD active subscribers reached 1.74 million, up 67% year over year; full EU approval is expected no earlier than December 2026, and management aims to obtain unified EU approval by the first quarter of 2027. Despite the positive progress, Goldman Sachs believes pressure from competitors such as Waymo should not be underestimated, and lists competition in autonomous driving as one of the main downside risks.
Optimus: Pace More Conservative Than Market Expectations
The humanoid robot Optimus was another highly scrutinized topic this quarter.
Musk confirmed on the earnings call that Optimus has begun mass production at the Fremont factory, but his description of the production ramp was quite cautious—the target output within 12 months is 10,000 to 20,000 units, below some of the market's previous optimistic expectations. This batch of robots will first be used internally at Tesla's Tesla Academy for self-training and data generation. The target for commercial sales to external customers has been pushed to the end of 2027, and consumer applications are even more distant.
Musk described the Optimus production ramp as an "S-curve," emphasizing that "ten thousand things need to go right simultaneously," with the slowest component or process determining the overall ramp pace. He singled out the hand (dexterous hand) as the biggest current hardware bottleneck, noting that achieving human-level dexterity and long-term reliable operation remains a challenge.
On the compute side, Tesla plans to integrate its next-generation AI5 chip into Optimus in April 2027; management said the chip's compute power is roughly 10 times that of the current AI4 chip, which will significantly enhance complex behavior capabilities.
According to a JPMorgan research report, its stance on the entire humanoid robot supply chain has therefore become more cautious, and it remains wary of expectation-revision risk facing Unitree, Estun, and UBTech over the next one to three months.
Energy Storage and Auto Demand: Substantive Highlights
The energy storage business posted a gross margin of 33.1%, a sharp sequential increase; management said Megapack capacity is "almost sold out for 2027," and the energy business's backlog hit a record high. The Texas Megafactory has begun production.
Notably, third-quarter energy storage revenue of $2.881 billion came in below Goldman Sachs' forecast of $3.749 billion, and management attributed part of the gap to tariff refunds to energy customers; Goldman Sachs said it will continue to track ASP (average selling price) trends and the pricing environment.
On auto demand, management said the passenger vehicle backlog is at a four-year high, with record deliveries achieved in Canada, Australia, Japan, and Taiwan, and Tesla Semi has also begun mass production. Goldman Sachs raised its delivery forecasts for 2026 to 2028 to 1.84 million/1.95 million/2.03 million vehicles. On the supply chain side, battery availability remains one of the constraints on the global production ramp, but the company is advancing related capacity construction in Berlin, Texas, and Nevada.
Valuation "Fully Priced"
Despite the bright spots in business progress, mainstream Wall Street institutions remain highly unanimous in their view of Tesla stock.
Goldman Sachs maintains a Neutral rating with a 12-month target price of $360, based on a 150x P/E multiple applied to EPS forecasts for the next five to eight quarters (including stock-based compensation), implying about 7% downside from the current share price. Morgan Stanley maintains a Neutral rating with a target price of $400; its valuation model includes $44 for the core auto business, $145 for network services, $120 for Tesla Mobility, $35 for energy storage, and a discounted $56 allocation for humanoid robot value, which already fairly fully reflects long-term option value.
Goldman Sachs explicitly stated that the current valuation is "full," that profitability and free cash flow will remain under pressure in the near to medium term, and that the magnitude and pace of EPS improvement will be constrained by competitive pressure across multiple areas. Tesla's 12-month share price performance has lagged the S&P 500 by about 24% over the past year, reflecting the market's continued digestion of the premium while waiting for results to materialize.
In addition, Goldman Sachs said Tesla's CEO mentioned on the earnings call that SpaceX disclosed on its October 20 earnings call that SpaceX and Tesla have each established special committees composed of independent directors to discuss a potential business combination. This disclosure adds a new variable to Tesla stock, but information is currently limited; major institutions all said they will continue to monitor it and have not yet incorporated it into their valuation frameworks. Risk Disclosure and Disclaimer
Markets carry risk, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their particular circumstances. Investment based on this article is at the user's own risk.